Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
Location: 400 Seaport Court, Redwood City, CA, 94063, United States | Website: https://www.exicuretx.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
40.47M
52 Wk Range
$3.10 - $22.99
Previous Close
$6.07
Open
$5.85
Volume
224,241
Day Range
$5.60 - $6.55
Enterprise Value
36.4M
Cash
4.438M
Avg Qtr Burn
-2.063M
Insider Ownership
62.59%
Institutional Own.
6.15%
Qtr Updated
09/30/25
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Burixafor Details Multiple myeloma | Phase 2 Update |